NEW YORK (GenomeWeb News) – Microfluidic Systems yesterday said that it will use Applied Biosystems’ TaqMan assays in its Bioagent Autonomous Networked Detector for airborne pathogens.
Microfluidic Systems said that ABI will manufacture the assays, which can be used for detecting harmful pathogens. It noted that ABI’s TaqMan assays have provided more than 5.2 million anthrax screening tests through ongoing mail-screening applications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.